MedicarePartD.guide

A non-government resource built from CMS public data

Skyrizi on HealthSpring Extra Rx (S5617-382)

risankizumab

Covered, with prior authorization required.

Tier 5 (specialty tier). Quantity limit of 2.4 per 56 days.

$2,210.46
Patient pays / month, after deductible
$2,671.71
Patient pays / month, before the $615.00 deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

SKYRIZI Kit at a preferred retail pharmacy, from the plan's negotiated price of $8,841.84 for a month. Other covered strengths are listed below.

Prior authRequired on all 4 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 4 covered strengths and forms
FormTierPatient pays / monthLimits
SKYRIZI 150 mg/mL Injection5$10,845.80PA · 2 per 28 days
SKYRIZI Kit5$2,939.61PA · 1.2 per 56 days
SKYRIZI Kit5$2,210.46PA · 2.4 per 56 days
SKYRIZI 150 mg/mL Injection5$10,835.47PA · 2 per 28 days

Other IL-17 and IL-23 biologics on this plan

Verify with the plan before prescribing or filling. Member services: (800)222-6700. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5617-382